Soon, spray to help treat premature ejaculation
June 1st, 2010 - 2:06 pm ICT by ANIWashington, June 1 (ANI): An investigational new drug PSD502 has been found highly effective in treating primary premature ejaculation (PE).
Shionogi Pharma, Inc., a U.S.-based group company of Shionogi & Co., Ltd., has presented data summarizing the results of two pivotal studies of PSD502, a topical metered dose spray being developed for the treatment of PE.
Evaluating a combined total of 556 (randomized) and 536 (treated) men with primary PE in the United States, Canada and Europe over a three-month period, with more than 23,000 exposures to PSD502 recorded, the data demonstrated that men who were treated with PSD502 five minutes before intercourse by applying PSD502 via a topical metered dose spray had a time to ejaculation 5.5 times longer than those who used a placebo spray with the actual average measurement in minutes for drug and placebo.
A co-primary endpoint also looked at ejaculatory control and satisfaction. Point differences of 6.1 and 5.3 were observed between the PSD502 group and placebo in ejaculatory control and satisfaction domains, respectively.
“Combined results from the PSD502 pivotal studies are very exciting and this is a significant milestone,” said Ira D. Sharlip, clinical trial investigator and clinical professor of urology at the University of California, San Francisco.
These data were presented at the 2010 American Urological Association (AUA) Annual Meeting in San Francisco. (ANI)
- Spray helps them last six times longer in bed - Jun 01, 2010
- New topical spray is 'safe, effective treatment for premature ejaculation' - Apr 27, 2009
- Soon, a spray that can prevent premature ejaculation - Nov 20, 2009
- Soon, spray to treat premature ejaculation - Aug 08, 2010
- Now, premature ejaculation spray that delays orgasm 6 times longer than normal - Apr 07, 2009
- Spray to help men with premature ejaculation - Apr 07, 2009
- New gene therapy to effectively treat severe heart failure - Jun 04, 2010
- Fast acting erectile disorder drug goes on trial again - Feb 16, 2009
- Statins 'slow multiple sclerosis progression' - Apr 15, 2010
- Shark cartilage does not improve lung cancer survival - May 27, 2010
- Cutaneous application of nanoparticles may help treat erectile dysfunction - Apr 27, 2009
- 'Heat therapy' may help treat premature ejaculation - Mar 10, 2011
- Specific Vitamin E dose can benefit nonalcoholic steatohepatitis patients - Apr 29, 2010
- Drugs combo 'yields up to nearly 10 pc weight loss' - Apr 11, 2011
- Vaccine extends life of brain cancer patients - Apr 19, 2012
Tags: american urological association, california san francisco, clinical professor, clinical trial, endpoint, exposures, five minutes, group company, intercourse, ira, milestone, pharma, pivotal studies, placebo, premature ejaculation, randomized, shionogi, trial investigator, university of california san francisco, urology